Articles and Insights About Wearables for Clinical Trials

ActiGraph, the leading provider of medical-grade wearable activity and sleep monitoring solutions, has announced a new partnership with data analytics specialist VivoSense. The partnership will enhance the ability of both companies to deliver sponsor access to secure, regulated, analyzed, and contextualized sensor data from patients participating in pharmaceutical clinical trials. VivoSense is a regulatory compliant, cloud based platform for the analysis of wearable sensor data. VivoSense with VivoCapture provides pharmaceutical sponsors with secure access to contextualized sensor data, metadata, analyzed, and raw signals. The platform makes use of Azure authentication and authorization, computing, and storage in a regulated sensor data warehouse.

Vivonoetics, a Microsoft Cloud Partner, now offers VivoSense in both the Azure Marketplace and AppSource. VivoSense is a regulatory compliant, cloud based platform for the analysis of wearable sensor data. VivoSense with VivoCapture provides pharmaceutical sponsors with secure access to contextualized sensor data, metadata, analyzed and raw signals. The platform makes use of Azure authentication and authorization, computing, and storage in a regulated sensor data warehouse.

San Diego, CA, March 5, 2019 — Biometric sensor provider Indie Health announces its partnership with data analytics specialist VivoSense, to accelerate the delivery of actionable insights and accurate monitoring of patients’ health status. Combining VivoSense software with Indie Health sensor data ensures complete data integrity and structures it within a secure, regulatory-compliant and auditable environment.

VivoSense (Vivonoetics, Inc.) is proud to announce its partnership with Cardiac Insight, Inc. to expand the use of its wearable cardiac sensors in regulated pharmaceutical clinical trials and other healthcare research applications. To find out more, read our featured article in Business Wire.

VivoSense recognizes Rare Disease Day by minding the importance of discovering new advancements in research and clinical trials to care for those with rare diseases. There are approximately 30 million Americans living with rare diseases today, and research into new therapies is imperative for these patients.

VivoSense® now allows you to upload, import and store all your data on our Cloud server with these features:

Vivonoetics Inc., developer of VivoSense® visualization and analysis software, announced today that VivoSense® software will now be directly compatible with the Hexoskin health and activity monitoring smart shirt. Hexoskin, developed by Carré Technologies, is an elegant and cost-effective sensor garment designed for everyday use to unobtrusively measure detailed health and wellness data. VivoSense® is a sophisticated analysis and data management platform used by many elite clinical research institutions. VivoSense® compatibility with the Hexoskin consumer product will provide both researchers and quantified-self pundits a convenient and practical tool for the detailed interrogation and investigation of Hexoskin digital health data.

Vivonoetics Inc., developer of VivoSense® clinical research management and analysis software, announced today that they have partnered with Beddit, Inc., leading innovators in contact-free sleep and vital sign monitoring technology. The partnership will provide pharmaceutical companies and research organizations a practical and cost effective solution for long-term monitoring of sleep and vital signs, enabling more effective and efficient evaluation of new and existing treatments.